This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Latest papers
PatternExtract: A Facile, Scalable Pipeline for Point Pattern Generation from Spatial Imaging Data.
Computational and structural biotechnology journal · 2026
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.
Blood · 2024
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
Leukemia & lymphoma · 2024
Latest funding
- $1,453,500
Common precursor cells in diffuse large B-cell lymphoma: characterization, evolutionary trajectories and clinical applications.
CIHR · 2025 · Nominated PI
- $1,017,450
All roads lead to Rome: Tracing the evolutionary paths to diffuse large B-cell lymphoma
CIHR · 2022 · Co-investigator
- $105,000
Characterization of the Genetic Landscape of High-Grade B-cell Lymphoma to Elucidate Molecular Determinants and Identify Therapeutic Targets
CIHR · 2021 · Supervisor
5 publications.
PatternExtract: A Facile, Scalable Pipeline for Point Pattern Generation from Spatial Imaging Data.
Sridhar S, Kumar G, Ringler V, Gupta K, Jasoria S, Meng Z, Jaynes P, Tipgomut C, Rajan V, Scott D, Tripodo C, Kannan K, Jeyesekharan AD
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.
Smith MR, Jegede OA, Martin P, Till BG, Parekh SS, Yang DT, Hsi ED, Witzig T, Dave S, Scott D, Hanson C, Kostakoglu Shields L, Abdel-Samad N, Casulo C, Bartlett NL, Caimi PF, Al Baghdadi T, Blum KA, Romer MD, Inwards DJ, Lerner RE, Wagner LI, Little RF, Friedberg JW, Leonard JP, Kahl BS
Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
Kim JL, Gerrie AS, Savage KJ, Villa D, Scott D, Craig JW, Farinha P, Skinnider B, Slack G, Connors JM, Sehn LH, Venner C, Freeman CL
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
Ramsower CA, Rosenthal A, Robetorye RS, Mwangi R, Maurer M, Villa D, McDonnell T, Feldman A, Cohen JB, Habermann T, Campo E, Clot G, Bühler MM, Kulis M, Martin-Subero JI, Giné E, Cook JR, Hill B, Raess PW, Beiske KH, Reichart A, Hartmann S, Holte H, Scott D, Rimsza L
Lack of reproducibility of histopathological features in MYC-rearranged large B cell lymphoma using digital whole slide images: a study from the Lunenburg lymphoma biomarker consortium.
Natkunam Y, de Jong D, Farinha P, Gaulard P, Klapper W, Rosenwald A, Sander B, Tooze R, Advani R, Burton C, Gribben JG, Kersten MJ, Kimby E, Lenz G, Molina T, Morschhauser F, Scott D, Sehn L, Stevens W, Clear A, Baia M, Habi A, Elsensohn MH, Langlois-Jacques C, Maucort-Boulch D, Calaminici M
Common precursor cells in diffuse large B-cell lymphoma: characterization, evolutionary trajectories and clinical applications.
Principal investigators: Scott, David W
Keywords: Classification Systems; Common Precursor Cells; Tumour Evolution
All roads lead to Rome: Tracing the evolutionary paths to diffuse large B-cell lymphoma
Principal investigators: Morin, Ryan D
Keywords: Bioinformatics; Cancer Genomics; Clonal Evolution; Machine Learning
Characterization of the Genetic Landscape of High-Grade B-cell Lymphoma to Elucidate Molecular Determinants and Identify Therapeutic Targets
Principal investigators: Collinge, Brett J
Keywords: Genomics; Lymphoma; Molecular Classification; Mutational Landscape
The pathogenic and clinical significance of somatic TMEM30A mutations in diffuse large B cell lymphoma
Principal investigators: Steidl, Christian
Keywords: Biomarkers; Genomics; Lymphoma; Microenvironment; Pathogenesis; Somatic Mutations
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.